logo

ENTERO vs GTECJAINX: Stock Comparison

ENTERO HEALTHCARE SOLU L vs GTECJAINXUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ENTERO leads 8; GTECJAINX leads 0 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ENTEROGTECJAINX

Valuation lens

What price are you paying?

Market CapContext only
₹6,558 Cr
₹32 Cr
P/E RatioSame reading
52.28x
—
P/B RatioSame reading
3.88x
—
EPSENTERO has the higher reading
₹8.77 ✓
₹0.29
Book ValueContext only
₹402.67
₹0.43
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ENTERO is the larger company
₹6,558 Cr vs ₹32 Cr
EPS
ENTERO has higher earnings per share
₹8.77 vs ₹0.29
Revenue Growth (TTM YoY)
ENTERO has faster revenue growth
42.6% vs -12.42%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
ROE
ENTERO has a higher ROE
1.6% vs -5.26%
ROCE
ENTERO has a higher ROCE
2.01% vs -4.28%
Net Margin
ENTERO has a higher net margin
1.75% vs -11.33%
Operating Margin
ENTERO has a higher operating margin
9.99% vs -6.55%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricENTEROGTECJAINX
SectorConsumer ServicesConsumer Services
IndustryPharmacy RetailE-Learning

Price

MetricENTEROGTECJAINX
Live Price₹1,503.9₹33.34
Day Change-5.12%-3.56%
Volume1.65 L2,191
52-Week High₹1,920₹39.55
52-Week Low₹944₹15.54
Distance from 52W High-21.67%-15.7%

Valuation

MetricENTEROGTECJAINX
Market Cap₹6,558 Cr₹32 Cr
P/E Ratio52.28x—
P/B Ratio3.88x—
EPS₹8.77₹0.29
Book Value₹402.67₹0.43
Dividend Yield0%0%

Growth

MetricENTEROGTECJAINX
Revenue Growth (TTM YoY)42.6%-12.42%
EPS Growth (TTM YoY)9.1%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricENTEROGTECJAINX
ROE1.6%-5.26%
ROCE2.01%-4.28%
Net Margin1.75%-11.33%
Operating Margin9.99%-6.55%
Debt to Equity0.06x0.14x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricENTEROGTECJAINX
Promoter Holding14.4%▼ 0.01 pp61.26%
FII Holding4.37%▲ 0.34 pp0%
DII Holding15.48%▼ 1.14 pp0%
Public Holding27.75%▲ 0.82 pp38.74%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and GTECJAINX.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.